7 182

Cited 47 times in

Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes

 Yun-Gyoo Lee  ;  Inho Kim  ;  Sung-Soo Yoon  ;  Seonyang Park  ;  June Won Cheong  ;  Yoo Hong Min  ;  Jeong-Ok Lee  ;  Soo-Mee Bang  ;  Hyeon Gyu Yi  ;  Chul Soo Kim  ;  Yong Park  ;  Byung-Soo Kim  ;  Yeung-Chul Mun  ;  Chu-Myoung Seong  ;  Jinny Park  ;  Jae Hoon Lee  ;  Sung-Yong Kim  ;  Hong Ghi Lee  ;  Yeo-Kyeoung Kim  ;  Hyeoung-Joon Kim 
 British Journal of Haematology, Vol.161(3) : 339-347, 2013 
Journal Title
 British Journal of Haematology 
Issue Date
The present study aimed to directly compare the efficacy and safety of azacitidine and decitabine in patients with myelodysplastic syndromes (MDS). We compared the overall response rate (ORR) (complete responses, partial responses, marrow complete responses, and haematological improvements), overall survival (OS), event-free survival (EFS), time to leukaemic transformation, and adverse outcomes between azacitidine and decitabine. To minimize the effects of treatment selection bias in this observational study, adjustments were made using the propensity-score matching method. Among 300 patients, 203 were treated with azacitidine and 97 with decitabine. Propensity-score matching yielded 97 patient pairs. In the propensity-matched cohort, there were no significant differences between the azacitidine and decitabine groups regarding ORR (44% vs. 52%), OS (26 vs. 22.9 months), EFS (7.7 vs. 7.0 months), and rate of leukaemic transformation (16% vs. 22% at 1 year). In patients ≥ 65 years of age, survival was significantly better in the azacitidine group (P = 0.017). Patients who received decitabine experienced more frequent episodes of grade 3 or 4 cytopenia and infectious episodes. We found that azacitidine and decitabine showed comparable efficacy. Among patients ≥ 65 years of age, survival was significantly better in the azacitidine group (ClinicalTrials.gov Identifier: NCT01409070).
Full Text
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Min, Yoo Hong(민유홍) ORCID logo https://orcid.org/0000-0001-8542-9583
Cheong, June-Won(정준원) ORCID logo https://orcid.org/0000-0002-1744-0921
RIS (EndNote)
XLS (Excel)
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.